Richard Harris

Award-winning journalist Richard Harris has reported on a wide range of topics in science, medicine and the environment since he joined NPR in 1986. In early 2014, his focus shifted from an emphasis on climate change and the environment to biomedical research.

Harris has traveled to all seven continents for NPR. His reports have originated from Timbuktu, the South Pole, the Galapagos Islands, Beijing during the SARS epidemic, the center of Greenland, the Amazon rain forest, the foot of Mt. Kilimanjaro (for a story about tuberculosis), and Japan to cover the nuclear aftermath of the 2011 tsunami.
In 2010, Harris' reporting revealed that the blown-out BP oil well in the Gulf of Mexico was spewing out far more oil than asserted in the official estimates. That revelation led the federal government to make a more realistic assessment of the extent of the spill.

Harris covered climate change for decades. He reported from the United Nations climate negotiations, starting with the Earth Summit in Rio de Janeiro in 1992, and including Kyoto in 1997 and Copenhagen in 2009. Harris was a major contributor to NPR's award-winning 2007-2008 "Climate Connections" series.

Over the course of his career, Harris has been the recipient of many prestigious awards. Those include the American Geophysical Union's 2013 Presidential Citation for Science and Society. He shared the 2009 National Academy of Sciences Communication Award and was a finalist again in 2011. In 2002, Harris was elected an honorary member of Sigma Xi, the scientific research society. Harris shared a 1995 Peabody Award for investigative reporting on NPR about the tobacco industry. Since 1988, the American Association for the Advancement of Science has honored Harris three times with its science journalism award.

Before joining NPR, Harris was a science writer for the San Francisco Examiner. From 1981 to 1983, Harris was a staff writer at The Tri-Valley Herald in Livermore, California, covering science, technology, and health issues related to the nuclear weapons lab in Livermore. He started his career as an AAAS Mass Media Science Fellow at the now-defunct Washington (DC) Star.

Harris is co-founder of the Washington, D.C., Area Science Writers Association, and is past president of the National Association of Science Writers. He serves on the board of the Council for the Advancement of Science Writing.

A California native, Harris returned to the University of California-Santa Cruz in 2012, to give a commencement address at Crown College, where he had given a valedictory address at his own graduation. He earned a bachelor's degree at the school in biology, with highest honors.

A major medical association today suggested that doctors who treat people with Type 2 diabetes can set less aggressive blood sugar targets. But medical groups that specialize in diabetes sharply disagree.

Half a dozen medical groups have looked carefully at the best treatment guidelines for the 29 million Americans who have Type 2 diabetes and have come up with somewhat differing guidelines.

Flu is still rampant across the United States, but the Centers for Disease Control and Prevention reports that the epidemic has peaked. It eased a bit last week, for the second week in a row.

Influenza is still claiming lives. The CDC reported 17 flu deaths among children last week, bringing the total pediatric deaths to 114. Adult deaths from the flu are not tracked directly.

The technology that drives science forward is forever accelerating, but the same can't be said for science communication. The basic process still holds many vestiges from its early days — that is the 17th century.

Some scientists are pressing to change that critical part of the scientific enterprise.

Here's what they're confronting: When researchers studying the biology of disease make a discovery, it typically takes nine months for them to get their results published in a journal.

A quarter of a million Americans die every year from sepsis, which is the body's reaction to overwhelming infection. This cascade of organ failure can be nipped in the bud if health care workers know it's ramping up, but that's often not easy to do.

This story of a man who nearly died in the hospital actually started in the woods of Washington's Cascade Mountains last summer.

"I was cutting for a logging outfit up on these rock cliffs and I felled a 150-foot fir tree into [some] maple trees," says Kristopher Kelly, a 51-year-old lumberjack. The maples "had a bunch of dead tops — they call 'em widow makers," Kelly says. "You don't want to get under them because they'll make you a widow."

Federal health officials say that, as they anticipated, the flu vaccine isn't very effective this year — but they say it has still prevented thousands of serious illnesses and deaths.

The Centers for Disease Control and Prevention figures that, overall, the flu vaccine is 36 percent effective at preventing disease. One bright point for parents of young kids: Children ages 6 months to 8 years responded significantly better to the vaccine than older Americans.

The peak of the flu season could still be several weeks away, federal health officials cautioned Friday.

"We may be on track to break some recent records," said Dr. Anne Schuchat, acting director of the Centers for Disease Control and Prevention. Nearly all states are still reporting widespread flu activity, with less severe reports only coming from Oregon and Hawaii.

"Flu is incredibly difficult to predict and we don't know if we've hit the peak yet," Schuchat said in a call with reporters. "We could still see several more weeks of increased activity."

The current flu season is still getting worse, federal health officials said Friday. And it continues to take a toll on children.

The Centers for Disease Control and Prevention reported an additional 16 flu deaths among children, bringing the nationwide total this season for youngsters to 53.

Researchers say they have taken a step toward developing a blood test that would detect eight common cancers, possibly even before symptoms appear.

As they report Thursday in the journal Science, they're hoping their idea would eventually lead to a $500 test that can screen for cancer and identify people with the disease when it's in its earliest stages and more treatable.

But they have a long way to go.

Copyright 2018 NPR. To see more, visit http://www.npr.org/.

ARI SHAPIRO, HOST:

Pages